Cencora (COR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
COR gains on strong GLP-1 and specialty drug growth, but margin pressure and fierce competition pose ongoing risks.
COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
![]() ABG 11 months ago | Other | €0.51 Per Share |
![]() ABG 9 May 2024 | Other | €0.51 Per Share |
![]() ABG 8 Feb 2024 | Other | €0.51 Per Share |
![]() ABG 9 Nov 2023 | Other | €0.51 Per Share |
![]() ABG 10 Aug 2023 | Other | €0.48 Per Share |
6 Aug 2025 (In 1 week) Date | | 3.82 Cons. EPS | - EPS |
29 Jul 2025 Date | | - Cons. EPS | - EPS |
7 May 2025 Date | | - Cons. EPS | - EPS |
29 Apr 2025 Date | | - Cons. EPS | - EPS |
29 Jan 2025 Date | | - Cons. EPS | - EPS |
![]() ABG 11 months ago | Other | €0.51 Per Share |
![]() ABG 9 May 2024 | Other | €0.51 Per Share |
![]() ABG 8 Feb 2024 | Other | €0.51 Per Share |
![]() ABG 9 Nov 2023 | Other | €0.51 Per Share |
![]() ABG 10 Aug 2023 | Other | €0.48 Per Share |
6 Aug 2025 (In 1 week) Date | | 3.82 Cons. EPS | - EPS |
29 Jul 2025 Date | | - Cons. EPS | - EPS |
7 May 2025 Date | | - Cons. EPS | - EPS |
29 Apr 2025 Date | | - Cons. EPS | - EPS |
29 Jan 2025 Date | | - Cons. EPS | - EPS |
Medical - Distribution Industry | Healthcare Sector | Robert P. Mauch PharmD CEO | XBER Exchange | US03073E1055 ISIN |
US Country | 42,000 Employees | 14 Feb 2025 Last Dividend | 16 Jun 2009 Last Split | - IPO Date |
Cencora, Inc., previously known as AmerisourceBergen Corporation, represents a cornerstone in the pharmaceutical distribution industry. Established in 2001 and headquartered in Conshohocken, Pennsylvania, the company specializes in sourcing and distributing pharmaceutical products across various markets. Its operation spans a comprehensive array of services targeted at facilitating the accessibility and distribution of pharmaceuticals, healthcare products, and related services. Cencora's business operations are segmented into U.S. Healthcare Solutions and International Healthcare Solutions, each catering to a diverse range of customers and needs within the healthcare and pharmaceutical sectors.
U.S. Healthcare Solutions:
International Healthcare Solutions: